ORIGINAL RESEARCH article

Front. Neural Circuits, 14 August 2023

Volume 17 - 2023 | https://doi.org/10.3389/fncir.2023.1252759

Profiling neurotransmitter-evoked glial responses by RNA-sequencing analysis

  • School of Life Sciences and Technology, ShanghaiTech University, Shanghai, China

Abstract

Fundamental properties of neurons and glia are distinctively different. Neurons are excitable cells that transmit information, whereas glia have long been considered as passive bystanders. Recently, the concept of tripartite synapse is proposed that glia are structurally and functionally incorporated into the synapse, the basic unit of information processing in the brains. It has then become intriguing how glia actively communicate with the presynaptic and postsynaptic compartments to influence the signal transmission. Here we present a thorough analysis at the transcriptional level on how glia respond to different types of neurotransmitters. Adult fly glia were purified from brains incubated with different types of neurotransmitters ex vivo. Subsequent RNA-sequencing analyses reveal distinct and overlapping patterns for these transcriptomes. Whereas Acetylcholine (ACh) and Glutamate (Glu) more vigorously activate glial gene expression, GABA retains its inhibitory effect. All neurotransmitters fail to trigger a significant change in the expression of their synthesis enzymes, yet Glu triggers increased expression of neurotransmitter receptors including its own and nAChRs. Expressions of transporters for GABA and Glutamate are under diverse controls from DA, GABA, and Glu, suggesting that the evoked intracellular pathways by these neurotransmitters are interconnected. Furthermore, changes in the expression of genes involved in calcium signaling also functionally predict the change in the glial activity. Finally, neurotransmitters also trigger a general metabolic suppression in glia except the DA, which upregulates a number of genes involved in transporting nutrients and amino acids. Our findings fundamentally dissect the transcriptional change in glia facing neuronal challenges; these results provide insights on how glia and neurons crosstalk in a synaptic context and underlie the mechanism of brain function and behavior.

Introduction

Neurons and glia are the two major cell types in the central nervous system (CNS). Whereas neurons are the major mediators for all aspects of brain function, glia, although abundantly seen, are usually considered passive bystanders that provide nutrient and support (; ; ). Evolutionally, the percentage of glial cells increases with the complexity of organisms, from 16% in nematodes, 20% in Drosophila, 50% in mice, to 90% in human brains, suggesting that glia play a broader and more complex role (; ; ; ; ). Intriguingly, glial cells among these species are similar in the morphology and function. For instance, fly glia include cortex glia, astrocyte-like glia, ensheathing glia, and the surface glia (perineurial glia and subperineurial glia). Whereas the outermost perineurial glia (PNG) and subperineurial glia (SPG) are involved in forming the blood–brain barrier for protecting the nervous system, cortex glia, like mammalian astrocytes, are responsible to wrap around the cell bodies of neurons and provide them with nutrients. Astrocyte-like glia and ensheathing glia are both glia associated with neuropils, function similarly as mammalian astrocytes and oligodendrocytes, for mediating synapse formation, synaptic function, and axon insulation (; ; ; ; ).

Lately, accumulating evidence has revealed new and exciting roles of glia, participating in the regulation of nervous system function in an active manner. In both Drosophila and mammals, glia have been shown as the third component in the tripartite synapse (; ; ); they regulate synapse formation and synaptic transmission by responding to neurotransmitters, the chemical molecules that convey signals after releasing into the synaptic cleft. In nanoscale, neurotransmitters are released to activate the corresponding receptors on the postsynaptic membrane, propagating the signaling relay from the presynaptic to the postsynaptic compartment. Like postsynaptic compartments, glia, also express receptors on the membranes that respond to these neurotransmitters. In addition, glia express transporters which uptake and recycle extra neurotransmitters released into the cleft. Thus, it is crucial to consider how glia respond to neurotransmitters and incorporate these effects when analyzing the synaptic transmission for larger contexts.

Neurons secrete a variety of neurotransmitters, including acetylcholine (ACh), gamma-aminobutyric acid (GABA), glutamate (Glu), dopamine (DA), adenosine triphosphate (ATP), serotonin (5-HT), opioids, endocannabinoids, and etc. (; ; ; ; ; ; ; ). These neurotransmitters, some also released by glia, convey activation or inhibitory signals. Here we developed a protocol purifying glia from the adult fly brains ex vivo. By RNA-sequencing analysis, we found that incubation with different types of neurotransmitters triggers differential gene expressions in glia. Distinct and overlapping patterns of these transcriptomes were identified, implicating that different types of neurotransmitters induce unique signature patterns in gene expression; interconnected crosstalk among them also occurred at the transcriptional level. A general metabolic suppression in glia was also evoked by all types of neurotransmitters except the DA, which upregulates a number of genes involved in transporting nutrients and amino acids.

Results

Purification and RNA-sequencing analysis of adult fly glia ex vivo

To investigate how glia respond to neurotransmitters, we developed a protocol analyzing gene expression in adult fly glia (Figure 1A). Adult fly brains expressing a membranous GFP (UAS-mCD8GFP) under the control of a pan-glial driver repo-GAL4 (repo > mCD8GFP) were dissected and incubated with different types of neurotransmitters (10 mM) for 30 min. The neurotransmitters we used include: Glu, DA, ATP, ACh, and GABA. GFP-positive adult fly glia were purified by the fluorescence activated cell sorting (FACS) and total RNAs were extracted from these glia for further sequencing analysis. Expression changes of genes of interest were verified again by the reverse transcription quantitative PCR (RT-qPCR). Due to the heterogeneity in the size and shape of glial cells, adult fly brain cells were suspended into single cells and sorted by the criteria whether the cells express GFP (Figure 1B). Interestingly, the sorting plot revealed that 8–10% of total cells were GFP-positive, correlating with the reported number of glia in adult fly brains (; ; ). After removal of cell debris, single GFP-positive glial cells were visualized by confocal microscopy (Figure 1C).

FIGURE 1

By RNA-sequencing analysis, we were able to analyze the glial response at the transcription level to each type of neurotransmitters; the differences in individual gene expression were compared. A total of 720 million reads of sequencing samples were obtained, with each transcriptome containing about 0.4 million reads in three biological replicates. A total of 16,107 genes were detected including 2,631 uncharacterized genes (annotated in CG number). Total 46,048 expressed transcripts including 18,763 new transcripts were identified. RSEM software was used to quantitatively analyze the expression level of transcripts, and TPM conversion was performed to homogenize the sequencing length and depth of transcripts, so to obtain standardized expression level of transcripts. According to the Violin plot showing the sample expression distribution, the gene expression level in each transcriptome is similar, ensuring the same amount of information collected from different transcriptomes (Figure 1D). In addition, about 9,000 genes were identified in each transcriptome as revealed by the sample expression distribution Upset plot, with over 7,800 overlapping genes identified in all six groups and the rest expressing in different groups (Figure 1E). Sample distance heatmap (Figure 1F) and PCA analysis (Figure 1G) revealed a strong correlation between the bio-replicated samples for each group treated with different neurotransmitters. These results suggest that the difference between replicates of each group is relatively large, whereas among replicates themselves is small. The RNA-sequencing results are therefore reliable, consistent, and qualified.

Identification of differentially expressed genes in neurotransmitter-treated adult fly glia

Next, genes differentially expressed among these groups were analyzed. Gene set analysis was carried out and the Upset plot revealed the total number of differentially expressed genes (DEGs) in adult fly glia upon neurotransmitter addition. A total of 2,259 DEGs were identified in Glu-treated glia, whereas only 371 DEGs were detected in ATP-treated glia (Figure 2A). Among these identified DEGs, 1,171 upregulated and 1,088 downregulated genes were identified in Glu-treated glia, whereas only 80 upregulated and 291 downregulated genes were identified in ATP-treated glia (Figure 2B). As more upregulated genes were identified in the Glu and DA groups, more downregulated genes were detected in the ACh, GABA, and ATP groups (Figure 2B). These results suggest that neurotransmitters have differential effects on the glial gene expression. A heatmap of gene cluster analysis was drawn to compare the expression level of individual gene in each group (Figure 2C). Z score was used to standardize the gene expression: when the score is lower than the average value, z is negative; otherwise, it is positive. As shown in the heatmap, genes in the top panel (green label on the left) were mostly upregulated in the DA-treated glia compared to the control group, whereas the same set of genes were mostly downregulated in the GABA-, ACh-, or Glu-treated glia. Genes in the middle panel (blue label on the left) were mostly downregulated in glia treated with all five types of neurotransmitters. At last, genes in the bottom panel (red label on the left) exhibited a low expression in the control group, yet mostly upregulated in the Glu-treated glia (Figure 2C). Consistently, changes in some of these genes involved in signal transduction, metabolism, and function of glial cells were also verified by RT-qPCR in our hand (Supplementary Figures 1, 2).

FIGURE 2

On the other hand, DEGs categorized by different analyses revealed further information on the function of affected genes (Supplementary Figures 3–5). For instance, COG classification showed that most genes affected in all five groups of glia were poorly characterized (Group S), revealing unrecognized glial cell functions that remain to be investigated. GO annotation and KEGG analysis showed similar trends in the number of genes involved in different cellular processes or pathways for all five types of neurotransmitter-treated glia. Considering that neurotransmitters likely regulate glia in similar mechanisms, it is feasible that no dramatic change in one single type of cellular events is detected.

Neurotransmitters evoke changes in the expression of related receptors and transporters in adult fly glia

Despite that glia are not excitable cells, they utilize similar repertoires of synthesis enzymes, receptors, and transporters when transmitting the cellular signals in response to neurotransmitters (; ; ; ). Next, we analyzed the expression change in a list of genes characterized for their function in the synthesis, transport, and receptor-based signaling of neurotransmitters. Genes selected are the synthesis enzymes, transporters, and receptors for the five types of neurotransmitters and they are listed in Table 1.

TABLE 1

FunctionGene IDGeneAChATPDAGABAGlu
SynthesisFBgn0000303ChAT
FBgn0013672mt:ATPase6
FBgn0019644ATPsynB
FBgn0039830ATPsynC
FBgn0016120ATPsynD
FBgn0038224ATPsynE
FBgn0035032ATPsynF
FBgn0010612ATPsynG−
FBgn0016119ATPsynCF6
FBgn0016691ATPsynO
FBgn0011211blw
FBgn0010217ATPsynbeta
FBgn0020235ATPsyngamma
FBgn0028342ATPsyndelta
FBgn0004516Gad1+++
FBgn0000422Ddc
FBgn0001098Gdh
FBgn0036663CG9674
TransportersFBgn0270928VAChT+
FBgn0005775Con+
FBgn0052103SCaMC
FBgn0033911VGAT
FBgn0039915Gat−+−−
FBgn0034136DAT
FBgn0260964Vmat+
FBgn0031424VGlut
FBgn0010497dmGlut
FBgn0026439Eaat1+−
FBgn0026438Eaat2
ReceptorsFBgn0000036nAChRalpha1++
FBgn0000039nAChRalpha2
FBgn0015519nAChRalpha3+
FBgn0266347nAChRalpha4+
FBgn0028875nAChRalpha5+++++
FBgn0032151nAChRalpha6+++++
FBgn0086778nAChRalpha7+++++
FBgn0000038nAChRbeta1+
FBgn0004118nAChRbeta2
FBgn0031261nAChRbeta3−
FBgn0000037mAChR-A+
FBgn0037546mAChR-B+
FBgn0029909mAChR-C
FBgn0039747AdoR+−
FBgn0035538DopEcR++
FBgn0011582Dop1R1+
FBgn0266137Dop1R2
FBgn0053517Dop2R+
FBgn0260446GABA-B-R1++
FBgn0027575GABA-B-R2
FBgn0031275GABA-B-R3+
FBgn0019985mGluR+++
FBgn0004619GluRIA
FBgn0264000GluRIB+
FBgn0004620GluRIIA−−−−
FBgn0020429GluRIIB
FBgn0046113GluRIIC
FBgn0028422GluRIID●●
FBgn0051201GluRIIE−−
FBgn0262869Gfrl+

A list of genes involved in the synthesis, transport, and receptor-based signaling of neurotransmitters.

The changes in the expression of these genes are denoted by “+” (increased expression), “−” (decreased expression), “ ” (no change), and “●” (not tested) upon adding different types of neurotransmitters.

As shown by the Volcano plot and heatmap in Figure 3, significant changes in the expression of genes listed in Table 1 were uncovered. We used “+” or “−” symbol for indicating genes with increased expression (the adjusted p-value < 0.05, log2FC > 1) or decreased expression (the adjusted p-value < 0.05, log2FC < −1), respectively in Table 1. A color tile along with the number designation was shown in the upper-right corner of the heatmap in Figure 3 for indicating the difference in gene expression. By default, a three color scale is used with blue indicating low expression values (2–4-fold lower), white indicating similarly expressed genes, and red representing highly expressed genes (2–4-fold higher). Genes with expression differentially affected by the neurotransmitters were selected and shown in the Volcano plot. Overall, neurotransmitters failed to evoke significant change in the expression of synthesis enzymes and triggered more change in the receptor expression. Among the five types of neurotransmitters, Glu activate the expression of Table 1 genes more significantly. Whereas Glu mainly evoked upregulation in receptor expression, GABA rarely caused any increase, correlating with its inhibitory function (Figures 3D, E).

FIGURE 3

Specifically, ACh increased the expression of glutamate decarboxylase 1 (GAD1) and nicotinic acetylcholine receptor alpha 1, 5-7 (nAChRα1, 5-7), yet decreased the expression of Glutamate receptor IIA (GluRIIA) (Control vs. ACh, Figure 3A). ATP also decreased the GluRIIA expression, and increased the expression of nAChRα1, 5-7 as potently as ACh (Control vs. ATP, Figure 3B). DA upregulated the GABA transporter GAT and the Excitatory amino acid transporter 1 (Eaat1), both are transporters for neurotransmitter trafficking (Control vs. DA, Figure 3C). Whereas GABA did not elicit a dramatic change in the overall gene expression, Glu elicited increased expression in nAChRα1, 5-7, Dopamine/Ecdysteroid receptor (DopEcR), metabotropic GABA-B receptor subtype 1 (GABA-B-R1), metabotropic Glutamate Receptor (mGluR), and Glutamate receptor IB (GluRIB) (Figure 3E).

Neurotransmitters trigger changes in the expression of genes dictated for glial function

It has been widely recognized that glia are part of the tripartite synapse and respond to neuronal signals by calcium wave propagation, a functional way to relay signals to adjacent or distal glia via gap junctions (; ; ; ; ; ). To further investigate whether neurotransmitters trigger change in genes involved in these aspects, a list of genes encoding channels, transporters, and gap junctions were compiled and analyzed (Table 2). Volcano plot and heatmap were also illustrated in Figure 4, with changes in the expression level of these genes described similarly in Table 1 and Figure 3. Interestingly, expressions of most genes in these categories were upregulated upon ATP, DA, or Glu addition, whereas some inhibitory effects were seen in the group of ACh- and GABA-treated glia. These results suggest that in general neurotransmitters trigger glial activation.

TABLE 2

FunctionGene IDGeneAChATPDAGABAGlu
Glial functionFBgn0263006SERCA+
FBgn0015776nrv1−−
FBgn0015777nrv2+−
FBgn0032946nrv3++++
FBgn0027108Inx2−+−
FBgn0265274Inx3−+−
FBgn0027107Inx6●●●●
FBgn0027106Inx7+
FBgn0005775Con+
FBgn0024963GluClalpha++
FBgn0005614trpl+
FBgn0051547NKCC+−
FBgn0031039Shawn−
FBgn0025111Ant2
FBgn0037140SLC22A+
FBgn0036043Ae2+++
FBgn0259111Ndae1
FBgn0031998SLC5A11+

A list of genes involved in glial calcium activity.

These genes encode the proteins that function as calcium channel, gap junction, or transporter. The changes in the expression of these genes are denoted by “+” (increased expression), “−” (decreased expression), “ ” (no change), and “●” (not tested) upon adding different types of neurotransmitters.

FIGURE 4

Specifically, the expression of Sarco/endoplasmic reticulum Ca(2+)-ATPase (SERCA) was upregulated in the Glu-treated glia, suggesting that Glu triggers glial calcium activity. The expression of nervana 3 (nrv3) was upregulated in ATP- and Glu-treated glia, whereas nervana 2 (nrv2) was more highly expressed in the DA and GABA group. For gap junction genes, Innexin 2 (Inx2) and Innexin 3 (Inx3) were both upregulated in the DA-treated glia, yet downregulated in ACh- and GABA-treated glia. Moreover, genes encoding channels such as Glutamate-gated chloride channel subunit alpha (GluClalpha) and Ae2 in Glu group, and transient receptor potential-like (trpl), sodium potassium chloride cotransporter (NKCC) and SLC22A family member (SLC22A) in the DA group were more highly expressed. On the other hand, the expressions of Shawn and NKCC were downregulated in the DA- or ACh- and GABA-treated glia, respectively (Figure 4C). Taken together, these results suggest that neurotransmitters trigger changes in the expression of genes functioning in glial activity.

Neurotransmitters elicit metabolic changes in adult fly glia

Accumulating evidence has indicated that metabolic changes in neurons associate with brain dysfunction (; ; ; ; ; ). On the other hand, not a lot has been explored for how glia react to neuronal challenges from a metabolic view. Here we investigated metabolic genes differentially expressed in adult fly glia upon adding neurotransmitters. Searches done using the COG, GO, and KEGG databases identified genes in four types of metabolism including carbohydrates, lipid, amino acid, and alcohol (Table 3). Volcano plot and heatmap were also illustrated in Figure 5, with changes in the expression level of these genes described similarly in Table 1 and Figure 3. Overall, expressions of these metabolic genes were mostly downregulated in ACh- or GABA-treated glia, whereas ATP and Glu also evoked suppression for most genes but with some exception. These results suggest that metabolic suppression might be a general event when glia are in the presence of neurotransmitters. Interestingly, DA triggered increased expression for most metabolic genes, implicating a different response pathway for glia upon DA addition.

TABLE 3

FunctionGene IDGeneAChATPDAGABAGlu
Carbohydrate metabolismFBgn0041629Hexo2−−−−
FBgn0264574Glut1
FBgn0050035Tret1-1−−+−−
FBgn0033644Tret1-2
FBgn0003748Treh−+−−
FBgn0023477Taldo−−−
FBgn0028563sut1−−
FBgn0283499InR++
FBgn0038321Nagk−
FBgn0270927betaGlu−
FBgn0263048Gpdh3+
FBgn0020416Idgf1
FBgn0020415Idgf2−−−
FBgn0020414Idgf3−−−−
FBgn0026415Idgf4−−−−
FBgn0064237Idgf5
FBgn0013763Idgf6−−−
FBgn0050359Mal-A5−−−
FBgn0261955kdn+
FBgn0035968Slc45-1−
FBgn0050272MFS1
FBgn0031307MFS3−
FBgn0038799MFS9+−
FBgn0030452MFS10
FBgn0033234MFS12+
FBgn0010651MFS14−+−
FBgn0034392MFS15
FBgn0034611MFS16
FBgn0037140SLC22A+
FBgn0040383CG5254−−−
Lipid metabolismFBgn0038730Acsx1L●●●●
FBgn0038731Acsx1R●●
FBgn0038732Acsx2
FBgn0038733Acsx3−−−
FBgn0038734Acsx4
FBgn0267828Fatp1
FBgn0265187Fatp2
FBgn0034999Fatp3+−
FBgn0027601pdgy−+
FBgn0004797mdy−−
FBgn0031703Acsf2+−
FBgn0029945Acsf3
FBgn0034432Acadvl+
FBgn0029924CG4586−−
FBgn0032161CG4594−−
FBgn0037166CG11426−−−
Amino acid metabolismFBgn0037215beta-Man−−−−
FBgn0001124Got1−−−
FBgn0004516Gad1+++
FBgn0026439Eaat1+−
FBgn0026438Eaat2
FBgn0034911GlyT+
FBgn0001134Grd+
FBgn0001145Gs2−+−−
FBgn0039525CG5646−−
FBgn0030816CG16700
Alcohol metabolismFBgn0011768Fdh−−
FBgn0000055Adh−+−−
FBgn0017482T3dh−+−

A list of genes involved in metabolism.

Genes are categorized into metabolism related to carbohydrates, lipid, amino acid, and alcohol. The changes in the expression of these genes are denoted by “+” (increased expression), “−” (decreased expression), “ ” (no change), and “●” (not tested) upon adding different types of neurotransmitters.

FIGURE 5

Specifically, expressions of the metabolic genes including Hexosaminidase 2 (Hexo2), Trehalose transporter 1-1 (Tret1-1), and Imaginal disc growth factor 2-4, 6 (Idgf2-4, 6) in the Carbohydrate section were downregulated in the ACh- and GABA-treated glia. The expressions of Acyl-CoA synthetase X3 (Acsx3) and a putative lipid phosphatase CG11426 in the Lipid section were downregulated in ACh- and GABA-treated glia, while the expression of CG5254, a putative α-ketoglutarate transporter, was particularly affected by GABA (Figures 5A, D). These results indicate that the DEGs identified for ACh- and GABA-treated glia are similar.

On the other hand, a mixture of upregulated and downregulated genes were identified in the ATP- and Glu-treated glia. For the Carbohydrate section, the expressions of Glycerol-3-phosphate dehydrogenase 3 (Gpdh3), knockdown (kdn), Major Facilitator Superfamily Transporter 12 (MFS12), and SLC22A family member (SLC22A) were upregulated in both types of glia, although in different degrees. The expressions of glucose transporter Glut1 and Insulin-like receptor (InR) were specifically upregulated in Glu-treated glia. The expressions of putative lipid-related genes like CG4586, CG4594, and CG11426 were downregulated in both types of glia, with the expression of CG11426 most affected in the Glu-treated glia. In the Amino acid section, the expressions of Gad1, Eaat2, Glycine transporter (GlyT), and Glycine receptor (Grd) were upregulated in both ATP- and Glu-treated glia (Figures 5B, E).

In the DA-treated glia, most metabolic genes were upregulated in all four types of metabolism groups. The most affected genes included Major Facilitator Superfamily Transporter 9 (MFS9) and SLC22A in the Carbohydrate section; Fatty acid transport protein 3 (Fatp3), pudgy (pdgy), Acyl-CoA synthetase family member 2 (Acsf2), and Acyl-CoA dehydrogenase very long chain (Acadvl) in the Lipid section; Eaat1 and Gs2 in the Amino acid section. Interestingly, sugar transporter 1 (sut1) and the putative L-arginine solute carrier family 25 member 45 (SLC25A45, CG5646) were specifically downregulated in the presence of DA (Figure 5C). Taken together, these results suggest that metabolic suppression in glia is a general event upon neurotransmitter challenges except for DA.

Discussion

In the present study, we profiled the gene expression change in adult fly glia in the presence of different neurotransmitters. It is widely recognized that glia are the central elements in the tripartite synapse. They express the corresponding receptors, respond to neurotransmitters, mediate their uptake and recycling, and relay functional changes downstream. Thus, our findings provide both an overview on the gene expression change at the transcription level and implications on specific cellular events that orchestrate these glial responses. Analyses using different methods and qPCR results have also validated our RNA-sequencing results.

It is plausible to hypothesize that different types of neurotransmitters induces different cellular responses in glia. Thus, the overall profile of DEGs for each transcriptome should be distinct and separate from each other. Nonetheless, we identified profiles overlapping in number, pattern, and identity. ACh and Glu treatment both upregulate the nAChRs expression, suggesting that these receptors augment their responses by increasing their availability on the glial surface for receiving ACh. While both ACh and Glu increase the receptor expression of their own: Glu increases the expression of nAChRs, yet ACh decreases the expression of GluRIIA, suggesting a reciprocal effect of ACh and Glu on glia (Figure 6A). Furthermore, DA increases the expressions of GAT and Eaat1, transporter for GABA and Glu, respectively, whereas Glu decreases the GAT expression. These results suggest opposite effects of DA and Glu on the GABA-mediated signaling pathway. In contrast, GABA decreases the Eaat1 expression, indicating that DA and GABA also regulate Glu transport in opposite means. On the other hand, GABA inhibits its own transport by decreasing the GAT expression, suggesting a potential feedback loop on controlling the GABA availability. These results together point to an interactive and overlapping network of neurotransmitter-triggered glial responses (Figure 6B). Our results demonstrate the complexity in the interactive network at the transcription level. Of note, all five types of neurotransmitters fail to evoke a dramatic change in the expression of genes encoding synthesis enzymes for neurotransmitters, suggesting that glia do not respond to neurotransmitters by increasing their amounts, but to allocate the existing available signaling molecules for their trafficking and release, so to efficiently orchestrate the glial responses. Notably, the change in the gene expression also reflects a potential modulation on glial function. To this end, genes involved in propagating the glial calcium waves are also differentially expressed upon adding different types of neurotransmitters.

FIGURE 6

Recently, metabolic changes have emerged as critical mechanisms associated with brain dysfunction. A lot of observations have been made in neurons, whereas metabolic changes in glia in the context of synapse activation and neuronal function have not been largely explored. Our findings reveal that metabolic suppression in glia might be a general event upon neurotransmitter challenge. The expression of most metabolic genes in glia are suppressed when challenged with most types of neurotransmitters. Notably, DA triggers a general increase in the expression of metabolic genes including the choline transporter SLC22A, suggesting that DA acts differently from other types of neurotransmitters in regulating glial metabolism in the context of synaptic transmission. It has been shown that glia express a wide range of solute carrier family transporters that transport sugar, nutrients, amino acid, etc. (; ; ; ; ; ; ; ). In our study, neurotransmitters trigger changes in the expression of different SLC genes, implicating a role for SLC transporters in transducing neurotransmitter-triggered metabolic changes in glia.

Glia are the central elements of tripartite synapse and have long been recognized for their pivotal function in regulating a plethora of cellular processes underlying brain function and behavior. The present study provides insights on how glia respond to neurotransmitters at the transcription level. These findings illustrate a complex transcriptional network that includes characterized genes and the ones await to be further analyzed. Future work will be required to uncover how these DEGs uniquely relay the neurotransmitter-evoked signals in glia, so to construct the foundation underlying the mechanism of glia-neuron crosstalk in a synaptic context.

Materials and methods

Fly stock and husbandry

Flies were raised on a fly food (10 g agar, 52.5 g glucose, 60 g dry yeast, 59.1 g corn flour, 26.2 g brown sugar, 10.1 ml antiputrefactive #1 (418 ml propionic acid, 41.5 ml 85% phosphoric acid, and 540.5 ml ddH2O), and 12.5 ml antiputrefactive #2 (200 g methyl p-hydroxybenzoate add to 95% ethanol to 1 L) in a 12/12 h light/dark condition at 25°C with 70% humidity. All strains were obtained from Bloomington Stock Center, the Vienna Drosophila RNAi Center (VDRC), or as gifts from colleagues. The following stocks were used: repo-GAL4, UAS-mCD8GFP, UAS-mCD8GFP; repo-GAL4, UAS-GCamp6.0, UAS-Gcamp6.0; repo-Gal4.

Adult fly brain dissociation and cell collection

The flies used to sort glia were kept in incubators at 25°C, 70% humidity, 12/12 h light/dark condition, for 2∼3 days after eclosion. The brains expressing UAS-mCD8GFP; repo-GAL4 were dissected and dissociated as described (; ; ). Male and female adult flies of 100 each were dissected in cold Schneider’s Drosophila medium (SDM: Gibco) and immediately transferred to 1 ml cold SDM with 10 mM of different neurotransmitters added. Neurotransmitters used: acetylcholine chloride (Sigma A6625-25G), dopamine hydrochloride (MCE HY-B0451A), adenosine 5′-triphosphate disodium salt hydrate (Sigma A2383), γ-aminobutyric acid (MCE HY-N0067), and glutamate (Sigma G0355000). After incubated at room temperature on a shaker for 30 min, the brains were washed three times with 1 ml SDM for 10 min each time, then once again with 1XPBS and incubated in 300 μl SDM containing 100 U/ml papain (MCE, HY-P1645) and 2.5 mg/ml collagenase TL (Roche, 5401020001) for 30 min. After incubation for 5 min, the solution was mixed by pipets and centrifuged at 1,500 rpm for another 5 min for three times. A total of 400 μl cold SDM was added to inactivate enzyme. The supernatant was then filtered with 40 μm Cell strainer (Thermo/Fisher, T_70122363547), centrifuged at 400 g, 4°C for 7 min, then re-suspended with 500 μl SDM in a flow tube. Single-cell suspensions were screened by the BD FACS Aria Fusion Cell Sorter flow cytometry and sorted using a 100 μm nozzle. Flow-sorted glia were collected with 500 μl TRIzol Reagent (Thermo, 15596026) in the RNase-free centrifuge tubes. Average 30,000 glial cells were collected in each centrifuge tube and stored in liquid nitrogen.

RNA extraction

Total RNA was extracted from the purified glia using TRIZOL and Viral DNA/RNA Mini Purification Kit (MCE, HY-K1082). Then RNA quality was analyzed by the 2100 Bioanalyser (Agilent) and quantified using the ND-2000 (NanoDrop Technologies). Only high-quality RNA sample (OD260/280 = 1.8∼2.2, OD260/230 ≥ 2.0, RIN ≥ 6.5, 28S:18S ≥ 1.0, >1 μg) was used to construct the sequencing library.

Library preparation, sequencing, and processing

RNA-sequencing transcriptome libraries were prepared following the TruSeq™ RNA sample preparation Kit from Illumina using 1 μg of total RNA. Messenger RNA was isolated according to the polyA selection method by oligo(dT) beads and then fragmented by fragmentation buffer. Next, double-stranded cDNAs were synthesized using a SuperScript double-stranded cDNA synthesis kit (Invitrogen, CA) with random hexamer primers (Illumina). The synthesized cDNAs were subjected to end-repair, phosphorylation, and “A” base addition according to the Illumina’s library construction protocol. Libraries were size selected for cDNA target fragments of 300 bps on 2% Low Range Ultra Agarose followed by PCR amplified using the Phusion DNA polymerase (NEB) for 15 PCR cycles. After quantified by TBS380, paired-end RNA-seq sequencing library was sequenced with the Illumina HiSeq xten/NovaSeq 6000 sequencer (2X150 bp read length). The raw paired end reads were trimmed and quality controlled by SeqPrep and Sickle (). The original data after quality control, namely clean data (reads), were compared with the reference genome to obtain mapped data (reads) for subsequent transcriptome assembly and expression calculation, etc. At the same time, the quality of the comparison results of this transcriptome sequencing was evaluated, software used: HiSat2, TopHat2 ().

Differential expression analysis

In RNA-Seq analysis, gene expression levels were calculated by the number of clean reads (reads counts) located to genomic regions. RSEM software was used to quantitatively analyze the expression levels of genes and transcripts, so as to analyze the differential expression (DE) of genes among different samples (). DESeq2 software is used to analyze the DE, according to the comparison to the calculated DEGs read count data. The default screening criteria for significantly DEGs were adjusted using p-value < 0.05 and log2FC ≧ 1, when a gene met these two conditions at the same time, it was considered as a DEG ().

Pathway analysis

With the GO database, genes can be grouped by their function according to the biological processes (BP), cellular component (CC), and molecular function (MF). The DEGs were annotated with GO, and the results were mapped with up-down-regulated gene GO annotation histogram, using software Blast2go (; ). Using the KEGG database, genes can be classified according to the pathway they participate. KEGG annotation of DEGs can display the differential genes on the KEGG pathway map, and display the KEGG annotation pathway maps of up-regulated and down-regulated differential genes, using software KOBAS (). Using the EggNOG database, genes can be classified according to their function. COG annotation was made for DEGs displayed on the COG classification statistical map, using the software BLAST+, Diamond ().

Reverse transcription quantitative PCR

Quantitative PCR experiments were performed as described (). Total RNAs were extracted from the sorted glia and reverse-transcribed using the HiScript III RT SuperMix for qPCR (+gDNA wiper) (vazyme, R323-01). qPCR was performed in AB Quanut Studio 7 Real-Time PCR System using ChamQ Universal SYBR qPCR Master Mix (vazyme, Q711-02). Student’s t-test was used to statistic differences between control group and treated group, nsp > 0.05; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.

Calcium imaging

Calcium imaging experiments were performed using adult flies of 3–5 days old (; ). Flies were put on ice for immobilization, then glued into the dish. We used an external saline containing 108 mM NaCl, 5 mM KCl, 2 mM CaCl2⋅2H2O, 8 mM MgCl2⋅6H2O, 4 mM NaHCO3, 1 mM NaH2PO4, 1 mM NaH2PO4⋅2H2O, 10 mM glucose, 5 mM treharose⋅2H2O, 10 mM sucrose, 5 mM HEPES, and 1 μM TTX. The fly heads were opened under room temperature in external saline solution. Fluorescence microscope with high frame rate camera was used to record the calcium signals. Images were taken every 40 ms lasting 2 min, and a 10 mM concentration of neurotransmitter was added at 30 s for 5 s. Manual selection and Fiji was used for further analysis (). ΔF/F was calculated by fluorescence after addition of neurotransmitter subtracting the baseline fluorescence level (; ). To eliminate for baseline differences in F/F0 between samples, we normalized the “preconditioning” treatment for each cell to equal 0 ().

Statements

Data availability statement

The data presented in the study are deposited in the NCBI repository, accession number PRJNA992962.

Ethics statement

The manuscript presents research on animals that do not require ethical approval for their study.

Author contributions

MW and MH conceived and designed the study, analyzed the data, and wrote the manuscript. MW performed the experiments. Both authors read and approved the manuscript.

Funding

This work was supported by grants from ShanghaiTech and National Natural Science Foundation of China (32170962).

Acknowledgments

We thank the Bloomington Drosophila Stock Center, Vienna Drosophila RNAi Center, Tsinghua Fly Center, the Core Facility of Drosophila Resource and Technology, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Developmental Studies Hybridoma Bank for fly stocks. We also thank the Molecular Imaging Core Facility (MICF), the Molecular and Cell Biology Core Facility (MCBCF), and the Multi-Omics Core Facility (MOCF) at the School of Life Sciences and Technology, ShanghaiTech University for providing technical support. MH Lab members for discussion and comments.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fncir.2023.1252759/full#supplementary-material

Supplementary Figure 1

Reverse transcription quantitative PCR verification of common candidate genes selected from the RNA sequencing analysis (A–C) RT-qPCR verification of common candidate genes related to signal transduction (A), glial activity (B), and metabolism (C). Common genes include: nAChRα5, nAChRα6, nAChRα7, Gat, and GluRIIA (receptors and transporters); Tret1-1, Treh, ldgf3, ldgf4, and GS2 (metabolism). ns: p > 0.05; *: p < 0.05, **: p < 0.01, ***: p < 0.001, ****: p < 0.0001.

Supplementary Figure 2

Reverse transcription quantitative PCR verification of specific candidate genes in different groups selected from the RNA sequencing analysis (A–E) candidate genes were selected from the RNA-sequencing results and their expression changes were verified again using RT-qPCR. Genes selected include: Fdh, Gat1, Got, mGluR, Eaat1, and pdgy (receptors and transporters); ldgf2, ldgf6 (metabolism). ns: p > 0.05; *: p < 0.05, **: p < 0.01, ***: p < 0.001, ****: p < 0.0001.

Supplementary Figure 3

COG classification of RNA-sequencing analysis on glia treated with different types of neurotransmitters (A–E) The COG classification of RNA-sequencing results from glia treated with ACh (A), ATP (B), DA (C), GABA (D), and Glu (E).

Supplementary Figure 4

GO annotation of RNA-sequencing analysis on glia treated with different types of neurotransmitters. (A–E) The GO annotation of RNA-sequencing results from glia treated with ACh (A), ATP (B), DA (C), GABA (D), and Glu (E).

Supplementary Figure 5

KEGG pathway analysis of RNA-sequencing on glia treated with different types of neurotransmitters. (A–E) The KEGG pathway analysis of RNA-sequencing results from glia treated with ACh (A), ATP (B), DA (C), GABA (D), and Glu (E).

References

Summary

Keywords

glia, neurotransmitter, RNA-sequencing, metabolic suppression, signal transduction

Citation

Wang M and Ho MS (2023) Profiling neurotransmitter-evoked glial responses by RNA-sequencing analysis. Front. Neural Circuits 17:1252759. doi: 10.3389/fncir.2023.1252759

Received

04 July 2023

Accepted

25 July 2023

Published

14 August 2023

Volume

17 - 2023

Edited by

Ju Lu, University of California, Santa Cruz, United States

Reviewed by

Zhefeng Gong, Zhejiang University, China; Wei Zhou, Huazhong University of Science and Technology, China

Updates

Copyright

*Correspondence: Margaret S. Ho,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics